AstraZeneca buys cell therapy firm EsoBiotec for $1bn

by

British pharmaceutical giant AstraZeneca on Monday announced an agreement to buy Belgian cell therapy firm EsoBiotec for up to $1 billion, expanding its treatments for cancer.

Leave A Comment

Your email address will not be published. Required fields are marked *